What drove the 14% gain in 4893.T stock today?

The 14.00% gain appears driven by heavy volume and momentum buying rather than a single public announcement. Traders pushed price above the 50-day average to **JPY 171.00**, triggering follow-through buying in biotech names.

How does valuation look for 4893.T stock?

4893.T stock shows negative EPS at **-16.01** and PE **-10.18**, but strong cash per share near **JPY 90.49** and price-to-book around **1.80**. The firm is development-stage with high R&D intensity.

What is Meyka AI's short-term view for 4893.T stock?

Meyka AI's forecast model projects a monthly price of **JPY 140.72** for 4893.T stock, implying a **-17.71%** downside versus the **JPY 171.00** close. Forecasts are model-based and not guarantees.

What price targets should traders consider for 4893.T stock?

We suggest a conservative target **JPY 140.00**, a base target **JPY 190.00**, and a bull target **JPY 240.00**, tied to clinical progress and sector momentum.

JP Stocks

Up 14% at JPX close 12/03/2026: Noile-Immune Biotech (4893.T) catalyst & outlook

ByHuzaifa Zahoor March 12, 2026

The 4893.T stock surged 14.00% to JPY 171.00 at the JPX close on 12/03/2026, making Noile-Immune Biotech (4893.T) one of the day’s top gainers. Trading volume hit 3,719,700.00 shares, nearly twelve times the average volume. We review what drove the move, how fundamentals stack up and what technicals and analyst metrics imply for near-term trading of 4893.T stock.